Get the Stockscreener App
10.55
0.19%
0.02
After Hours:
10.55
Translational Development Acquisition Corp stock is traded at $10.55, with a volume of 781.
It is up +0.19% in the last 24 hours and up +0.19% over the past month.
Translational Development Acquisition Corp is a newly organized blank check company.
See More
Previous Close:
$10.53
Open:
$10.55
24h Volume:
781
Relative Volume:
0.02
Market Cap:
$231.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.19%
6M Performance:
+2.13%
1Y Performance:
+5.29%
1-Day Range:
$10.55
$10.55
1-Week Range:
$10.53
$10.55
52-Week Range:
$10.02
$10.56
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Name
Translational Development Acquisition Corp
Sector
Industry
Phone
(413) 204-2769
Address
52 E 83RD ST., NEW YORK
Compare TDAC vs CCXI, LION, XXI, APAD, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.55 | 230.69M | 0 | 0 | 0 | 0.00 |
|
CCXI
Churchill Capital Corp Xi
|
10.19 | 3.64B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
8.25 | 2.39B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
6.20 | 2.27B | 0 | 0 | 0 | 0.00 |
|
APAD
A Paradise Acquisition Corp
|
10.15 | 1.42B | 0 | 329.20K | -99,600 | 0.012 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.98 | 656.41M | 0 | 0 | 0 | 0.00 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-21 | Initiated | Northland Capital | Outperform |
Translational Development Acquisition Corp Stock (TDAC) Latest News
Stock Recap: Is LCII a speculative investmentMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Movement Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsPortfolio Update Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Stock Analysis: Will CIMG Inc announce a stock split2025 Short Interest & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Published on: 2026-02-21 02:25:17 - mfd.ru
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Axol Bioscience makes third acquisition in five years - Business Weekly
Axol Bioscience acquires ophthalmology business from Newcells Biotech - Cambridge Network
Can Translational Development Acquisition Corp. Equity Warrant stock double in next 5 yearsEntry Point & Daily Profit Maximizing Trade Tips - mfd.ru
Why Critical Metals Corp. stock could outperform in 2025Quarterly Market Review & Technical Entry and Exit Alerts - mfd.ru
Why NOVA stock remains resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Growth Review: What hedge funds are buying BJRIPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
What’s the profit margin of Translational Development Acquisition Corp.Share Buyback & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Will Translational Development Acquisition Corp. stock remain a Wall Street favoritePortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru
What drives Translational Development Acquisition Corp.’s stock price2025 Trading Recap & Verified Swing Trading Watchlist - mfd.ru
Big Picture: What are ClearPoint Neuro Incs recent SEC filings showingIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
CEO Moves: Is Albany International Corps growth already priced in2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Aug Drivers: What is the dividend yield of QUALCOMM IncorporatedJuly 2025 Institutional & Long-Term Safe Return Strategies - baoquankhu1.vn
Risk On: Can PSAPRF outperform under higher oil pricesJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn
Will Zeta Global Holdings Corp. stock split attract more investors2025 Macro Impact & AI Forecast Swing Trade Picks - mfd.ru
Why is Translational Development Acquisition Corp. Equity Warrant stock going downMarket Growth Summary & Weekly Return Optimization Plans - mfd.ru
Aug Shorts: Is Translational Development Acquisition Corp. a potential multi baggerBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Pharmagene Discovery Services Launches Following Acquisition of Human Tissue Laboratory - Lab Manager
Pullback Watch: Whats next for ALRS stockJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-02-01 08:56:35 - baoquankhu1.vn
Energy Moves: Can Translational Development Acquisition Corp outperform in the next rallyWeekly Market Report & Stock Portfolio Risk Control - baoquankhu1.vn
Update Report: Is Translational Development Acquisition Corp undervalued by DCF analysisEarnings Growth Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Bear Alert: Whats the profit margin of Translational Development Acquisition CorpWeekly Trade Summary & AI Enhanced Trading Alerts - baoquankhu1.vn
Short Covering: What is EDUCs 5 year growth outlookMarket Trend Review & Free Verified High Yield Trade Plans - baoquankhu1.vn
Investment Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsJuly 2025 Recap & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Trinity Capital Inc stock showing strong momentumTrade Analysis Summary & High Yield Stock Recommendations - baoquankhu1.vn
Is Qualigen Therapeutics Inc stock a value trap2025 Technical Overview & Daily Momentum Trading Reports - baoquankhu1.vn
Resalis Therapeutics Appoints Sandor Batkai as Medical Director - The Manila Times
Aug Fed Impact: Why is Translational Development Acquisition Corp Equity Warrant stock going downEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
Earnings Beat: Can Translational Development Acquisition Corp outperform in the next rally2025 Market Overview & Verified Entry Point Detection - baoquankhu1.vn
Is Translational Development Acquisition Corp. stock oversold or undervaluedEarnings Summary Report & Short-Term High Return Ideas - bollywoodhelpline.com
Why Translational Development Acquisition Corp. Equity Warrant stock is recommended by analystsJuly 2025 WrapUp & Smart Allocation Stock Tips - bollywoodhelpline.com
Is Heritage Insurance Holdings Inc stock a hidden gemJuly 2025 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
What catalysts could drive Vision Marine Technologies Inc. stock higherMarket Sentiment Report & Daily Entry Point Trade Alerts - bollywoodhelpline.com
What hedge fund moves indicate for General Electric Company (GCP) stockQuarterly Profit Report & Proven Capital Preservation Tips - bollywoodhelpline.com
Smart Money: Whats the profit margin of Translational Development Acquisition CorpJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Quarterly Earnings: What are Spring Valley Acquisition Corp IIs earnings expectationsQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - baoquankhu1.vn
Published on: 2026-01-17 09:56:53 - baoquankhu1.vn
Investment Recap: Whats next for DXLG stockMarket Trend Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
IPO Launch: Is Beasley Broadcast Group Inc in a bullish channelMarket Volume Summary & Verified Momentum Watchlists - baoquankhu1.vn
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers - Business Wire
Despite few big announcements at JPM, biotech investors optimistic - C&EN
PVP Labs to Present TAPHALGIN® Tetrapeptide Analgesic Platform at JP Morgan Healthcare Conference 2026 - BioSpace
Trendlines Suggest Mandeep Auto Industries Limited May Bottom Out SoonWeekly Trend Recap & Entry Point Confirmation Signals - Улправда
Earnings Beat: Does Translational Development Acquisition Corp. Equity Warrant stock trade at a discount to peers - ulpravda.ru
Why Translational Development Acquisition Corp. stock is seen as undervaluedMarket Volume Summary & Long-Term Capital Growth Ideas - ulpravda.ru
Is Translational Development Acquisition Corp. stock gaining market shareFootwear buying guidance for consistent weekly training mileage focuses on comfort and cushioning, making it recommended when comfort and support matter. - ulpravda.ru
Translational Development Acquisition Corp Stock (TDAC) Financials Data
There is no financial data for Translational Development Acquisition Corp (TDAC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.38%
1.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):